Pricing

ADC Therapeutics

1 follower

‌

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.

Industries

Biotechnology

Headquarters

Lausanne, Switzerland

Employees

201-500

Links

Org chart

Ameet Mallik

CEO

Ameet Mallik

Collapse

Kimberly Pope

Chief People Officer

Patrick van Berkel

Chief Scientific Officer

Michael Mulkerrin

Retired

Peter Graham

Chief Legal Officer

Jose Carmona

Chief Financial Officer

Kristen Harrington-Smith

Chief Commercial Officer

Mohamed Zaki

Chief Medical Officer

Michelle Celones

Director IMP Product Quality

Jada Baijnath

Director Of Strategic Planning And Chief Of Staff

Lisa Källebo

VP Corporate Controller Chief Accounting Officer

Jay Feingold

Chief Medical Officer And Senior Vice President

Stephen Dudek

Director, Global Strategy & Lifecycle Management

Jesse Stromeyer

Executive Director, Head Of Marketing

Niall McConnell

Head, Business Information Systems

Ruchi Mallya

Forecasting & Commercial Data Analytics

Jason Moss

Head, Chemical Development & Manufacturing

Alan S.

Senior Director, Head Of Data Management

David Ellis

Vice President, Head Of Regulatory Affairs

Tim Gillum

Executive Dir, Compliance & Quality Shared Services

Teams

+14

Leadership Team

17 members

+11

Clinical Operations and Development

14 members

Finance and Accounting

11 members

Similar companies

CRISPR Therapeutics

9 followers

Oxford Nanopore Technologies

5 followers

Novotech

4 followers

Arrowhead Pharmaceuticals

4 followers

Cerus

2 followers

ImmunityBio

2 followers

Thermo Fisher Scientific

155 followers

Agilent Technologies

63 followers

CSL

40 followers

Myriad Genetics

35 followers

bluebird bio

38 followers

Explore companies